Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts Helen Chapel, MA, MD, FRCP, Mary Lucas, BSc, Smita Patel, MBBS, MRCP, Martin Lee, BA, PhD, Charlotte Cunningham-Rundles, MD, PhD, Elena Resnick, MD, Laurence Gerard, PhD, Eric Oksenhendler, MD Journal of Allergy and Clinical Immunology Volume 130, Issue 5, Pages 1197-1198.e9 (November 2012) DOI: 10.1016/j.jaci.2012.05.046 Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 The percentages of patients in each of the 3 cohorts with various numbers of clinical phenotypes. Journal of Allergy and Clinical Immunology 2012 130, 1197-1198.e9DOI: (10.1016/j.jaci.2012.05.046) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig E1 Confirmation of clinical phenotyping using the original criteria. Journal of Allergy and Clinical Immunology 2012 130, 1197-1198.e9DOI: (10.1016/j.jaci.2012.05.046) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig E2 Time interval (years) between the diagnosis of CVID and the onset of complications used for clinical phenotyping in the 2 cohorts: extended Oxford (A) and DEFI (B). Dx, Diagnosis. Journal of Allergy and Clinical Immunology 2012 130, 1197-1198.e9DOI: (10.1016/j.jaci.2012.05.046) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions